New drug shows promise for Hard-to-Treat Graves' disease
NCT ID NCT05907668
First seen Feb 02, 2026 · Last updated May 19, 2026 · Updated 22 times
Summary
This study tested a drug called batoclimab in 35 adults with Graves' disease whose thyroid hormone levels were still high despite standard treatment. The goal was to see if the drug could bring thyroid hormones back to normal without needing higher doses of other medications. The study lasted 24 weeks and focused on safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAVES DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Site Number - 6505
Mainz, 55131, Germany
Conditions
Explore the condition pages connected to this study.